Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Coral Gables, FL
SEC filing record 1 source field available
Fiscal year end
31 December
CATALYST PHARMACEUTICALS, INC. has filed 1,380 SEC EDGAR filings since 30 Apr 2003

SEC filing history

Showing 751-775 of 1,000 matching filings.

Per page
25
Current page
31
4

FORM 4 FOR 11-06-2017

Filing date
07 Nov 2017
Reporting date
06 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 FOR 11-06-2017

Filing date
07 Nov 2017
Reporting date
06 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33057

8-K

Filing date
31 Oct 2017
Reporting date
31 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 FOR 09-05-2017

Filing date
05 Sep 2017
Reporting date
05 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33057

FORM 8-K

Filing date
30 Aug 2017
Reporting date
30 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33057

FORM 8-K

Filing date
09 Aug 2017
Reporting date
09 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-219259

424B3

Filing date
28 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-219259

EFFECT filing

Filing date
26 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
25 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-219259

S-3/A

Filing date
21 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
19 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEL AM File 333-219259

DEL AM

Filing date
13 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33057

FORM 8-K

Filing date
12 Jul 2017
Reporting date
12 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-219259

FORM S-3

Filing date
12 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33057

FORM 8-K

Filing date
26 May 2017
Reporting date
25 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 FOR 05-22-2017

Filing date
22 May 2017
Reporting date
22 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 FOR 05-11-2017

Filing date
15 May 2017
Reporting date
11 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33057

FORM 8-K

Filing date
10 May 2017
Reporting date
10 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33057

DEFINITIVE PROXY STATEMENT

Filing date
14 Apr 2017
Reporting date
25 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-33057

PRELIMINARY PROXY STATEMENT

Filing date
03 Apr 2017
Reporting date
25 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33057

FORM 8-K

Filing date
15 Mar 2017
Reporting date
15 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33057

FORM 8-K

Filing date
15 Mar 2017
Reporting date
15 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .